Company Overview
| Stock Name | Modern Chi Med |
|---|---|
| Stock Code | 01643 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事生產中成藥。 |
| Listing Date | 2021-01-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國河北省承德市津圍公路88號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.cdysjdyy.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.18 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 53,100,000 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|
| 26Q2 Regular Review | |
| Inclusion Pathway | None |
|---|---|
| Est. Threshold | --- |
| Analysis Result | 无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 1.26 |
|---|---|
| First Day Open | HK$ 1.17 |
| First Day Change | 6.78% |
| First Day Volume | 83169000.0 |
| First Day Turnover | 103949000.0 |
Use of Proceeds
| Use of Proceeds | 1、約44.0%或51.7百萬港元將用于提高及擴大產能，進一步生產我們的主要膠囊處方藥； 2、約16.8%或19.7百萬港元將用于擴大我們華南及華東的分銷網絡； 3、約10.2%或12.0百萬港元將用于提高品牌知名度，方法為媒體營銷及推廣； 4、約19.9%或23.4百萬港元將用于進一步加大研發力度、采購質量管理設備及 擴大產品組合，長遠而言為業務增值； 5、約3.4%或4.0百萬港元將用于升級IT系統； 6、約5.7%或6.6百萬港元將撥作營運資金及用作其他一般公司用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
Soochow Securities International Capital Limited CE BBG379
Overall Coordinators (2)
Joint Bookrunners (8)
Soochow Securities International Brokerage Limited CE AYA587
CS Wealth Securities Limited CE AAD244
SPDB International Capital Limited CE BFZ375
BOCOM International Securities Limited CE APJ121
YUE XIU SECURITIES COMPANY LIMITED CE ABQ722
SHANXI SECURITIES INTERNATIONAL LIMITED CE BEM330
SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927
Apricot Capital (Hong Kong) Limited CE ACX624
Joint Lead Managers (13)
Soochow Securities International Brokerage Limited CE AYA587
CS Wealth Securities Limited CE AAD244
SPDB International Capital Limited CE BFZ375
BOCOM International Securities Limited CE APJ121
YUE XIU SECURITIES COMPANY LIMITED CE ABQ722
SHANXI SECURITIES INTERNATIONAL LIMITED CE BEM330
SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927
Apricot Capital (Hong Kong) Limited CE ACX624
ZMF Asset Management Limited CE AWF641
DL SECURITIES (HK) LIMITED CE AZN279
FORTHRIGHT SECURITIES COMPANY LIMITED CE BGP713
CNI Securities Group Limited CE ATM582
MASTERLINK SECURITIES (HONG KONG) CORPORATION LIMITED CE ACS304
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 孫新磊 |
|---|---|
| Company Secretary | 謝婉婷,賈艷茹 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 現代生物科技集團控股有限公司(75%) |
|---|
